Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT
Theravance Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.58M | -15.53M | -12.7M | -16.53M | -11.66M | -8.51M | -8.95M | -15.64M | -22.09M | -14.26M | -44.43M | -8.19M | -25.95M | -32.03M | -35.31M | -52.41M | -79.68M |
Depreciation & Amortization | 1.05M | 695K | 762K | 979K | 1.18M | 1.42M | 937K | 924K | 978K | 2.02M | 1.31M | 2.2M | 1.48M | 2.39M | 2.61M | 2.42M | 2.29M |
Stock-Based Compensation | 4.88M | 5.83M | 4.96M | 5.38M | 5.23M | 5.82M | 6.26M | 6.26M | 7.02M | 6.95M | 8.53M | 9.71M | 14.54M | 16.92M | 14.37M | 14.94M | 15.83M |
Other Working Capital | -1.32M | 14.69M | 2.42M | 2.33M | 1.12M | 2.14M | -1.62M | -4.95M | -3.23M | 65.99M | -15.83M | -1.26M | -2.22M | -2.81M | -2.8M | -1.98M | -3.87M |
Other Non-Cash Items | 604K | 806K | 2.03M | 3.63M | 5.58M | 1.95M | 609K | 568K | 579K | -178.32M | 27.73M | -18.57M | -14.1M | -25K | 4.05M | -214K | 46K |
Deferred Income Tax | -1.85M | -6.59M | 90K | -561K | -513K | 1.88M | 1K | 1.32M | n/a | -5K | n/a | 5K | n/a | -22.17M | -25.3M | -1.76M | 4.75M |
Change in Working Capital | 51.94M | 13.89M | -342K | 2.69M | 4.12M | -3.41M | -1.34M | -5.87M | 2.29M | 59.56M | -15.28M | 120K | -2.05M | -7.52M | -5.87M | -13.09M | -13.11M |
Operating Cash Flow | 43.04M | -902K | -5.2M | -4.42M | -1.02M | -854K | -2.49M | -12.44M | -11.22M | -124.06M | -22.14M | -14.73M | -26.07M | -42.43M | -45.45M | -50.11M | -69.86M |
Capital Expenditures | n/a | -190K | -15K | -36K | -91K | -677K | -21K | -852K | -938K | -266K | n/a | -113K | -250K | -444K | -1.04M | -156K | -1.77M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -1.51M | n/a | 1.3M | 210K | -1.1B | 2.71M | 17K | 1.85M | n/a | 6K | n/a | n/a |
Purchase of Investments | -1.97M | -40.01M | -44.88M | -31.24M | -26.9M | n/a | n/a | -1K | -134.53M | -9.88M | -39.5M | -35.59M | -18.17M | -53.53M | -64.76M | -39.98M | -36K |
Sales Maturities Of Investments | 32.6M | 55.89M | 27.5M | 28.24M | 44.02M | n/a | n/a | 10.6M | 92.22M | 49.31M | 17.01M | 43.2M | 48.5M | 64.8M | 30M | 75.9M | 115.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 17.12M | 1.51M | n/a | 11.9M | -42.11M | 1.1B | 1.1B | 7.63M | 1.85M | 11.27M | 6K | 35.92M | 115.46M |
Investing Cash Flow | 30.63M | 15.69M | -17.4M | -3.03M | 17.03M | -677K | -21K | 11.05M | -43.05M | 39.16M | 1.08B | 7.51M | 31.92M | 10.82M | -35.79M | 35.77M | 113.7M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -631.6M | n/a | n/a | n/a | n/a | -5.03M | -5.7M |
Common Stock Repurchased | -874K | -528K | -397K | -463K | -1.72M | -30.78M | -31.4M | -81.13M | -56.24M | -35.79M | -94.7M | -347K | -1.45M | -455K | -2.29M | -727K | -5.59M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 133K | n/a | 375K | n/a | 173K | -1K | 446K | n/a | 314K | 4.28M | 487K | n/a | 604K | n/a | 2.86M | 3K |
Financial Cash Flow | -854K | -365K | -372K | -44K | -1.72M | -30.61M | -31.4M | -80.68M | -56.24M | -35.47M | -722.03M | 140K | -1.45M | 149K | -2.29M | 105.28M | -11.29M |
Net Cash Flow | 72.82M | 14.42M | -22.97M | -7.49M | 14.29M | -32.14M | -33.91M | -82.07M | -110.51M | -120.37M | 331.25M | -7.08M | 4.41M | -31.46M | -83.53M | 90.94M | 32.54M |
Free Cash Flow | 43.04M | -1.09M | -5.21M | -4.45M | -1.11M | -1.53M | -2.51M | -13.29M | -12.16M | -124.32M | -22.08M | -14.84M | -26.32M | -42.88M | -46.48M | -50.27M | -71.63M |